Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 7/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.68 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.68 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.68 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10982454 | 0.86 | TSPO (0.67) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL20263662 | 0.84 | TSPO (0.71) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL8523140 | 0.83 | TSPO (0.64) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| Pk-11195 SCHEMBL29354252 | 0.81 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| (R)Pk-11195 SCHEMBL29477174 | 0.81 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| (R)Pk-11195 SCHEMBL15118334 | 0.81 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| Pk-11195 SCHEMBL31060347 | 0.81 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| (R)Pk-11195 SCHEMBL29357086 | 0.81 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| (R)Pk-11195 SCHEMBL12790424 | 0.81 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| (R)Pk-11195 SCHEMBL7685386 | 0.81 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1087790-A2 | USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2001-04-04 | — | — | EP | claimed |
| WO-1999066958-A2 | USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1999-12-29 | — | — | WO | claimed |
| US-5776946-A | Peripheral benzodiazepine receptor ligands as antiinflammatory agents | MCGEER, EDITH G. (CA) | 1998-07-07 | — | — | US | claimed |
| US-5032595-A | Method of stimulating steroidogenesis with alpidem | FIDIA-GEORGETOWN INSTITUTE FOR THE NEUROSCIENCES (US) | 1991-07-16 | — | — | US | disclosed |